Optimize Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
726
-2
-0.3% -$1.12K 0.14% 220
2026
Q1
$409K Buy
728
+59
+9% +$37.8K 0.2% 192
2025
Q4
$453K Buy
669
+8
+1% +$5.45K 0.23% 173
2025
Q3
$422K Buy
661
+274
+71% +$166K 0.22% 187
2025
Q2
$208K Buy
+387
New +$185K 0.13% 212

Other funds holding IDXX

Optimize Financial's IDXX Position: Q2 2026 in Review

Optimize Financial reduced its Idexx Laboratories (IDXX) stake by 0.27% in Q2 2026, selling an estimated $1.12K and leaving 726 shares worth $382K. The position accounts for 0.14% of the portfolio, ranked #220.

Optimize Financial first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $453K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Optimize Financial held 726 shares of Idexx Laboratories worth $382K as of Q2 2026.
  • Optimize Financial sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up 0.14% of Optimize Financial's portfolio in Q2 2026, its #220 holding.
  • Optimize Financial first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Optimize Financial's Idexx Laboratories position peaked at $453K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.